ACE2 and infection: As it was discovered that ACE2 is the receptor for SARS-CoV2 entry into the cells, many authors raised a concern for the potential negative interactions between RAAS-targeting drugs (ACEI and ARBs) and SARS-Cov2: in fact, previous studies found that these medications may increase ACE2 levels, a fact that could potentially increase individual susceptibility to infection.